Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 28, 2007Journal of Clinical OncologyOpen Access

Age and Comorbidity As Independent Prognostic Factors in the Treatment of Non–Small-Cell Lung Cancer: A Review of National Cancer Institute of Canada Clinical Trials Group Trials

View Full Paper
Ask AI
Bookmark
Share

Authors

TATimothy R. AsmisOttawa HospitalKDKeyue DingQueen's UniversityLSLesley SeymourQueen's University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Asmis et al. (2007) studied this question.

synapsesocial.com/papers/6a71b75478a11c550e0bb84chttps://doi.org/10.1200/jco.2007.12.8322
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Estimating Treatment Benefits for the Elderly: The Effect of Competing Risks1996 · 283 citations
  2. 2Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials1995 · 2,870 citations
  3. 3Cancer burden in the aged1997 · 472 citations
  4. 4Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.182005 · 181 citations